BRIEF published on 04/07/2026 at 18:05, 2 months 15 days ago Oxurion reporte son assemblée générale annuelle des actionnaires Calendrier Financier Assemblée Générale Des Actionnaires Risques D'investissement Oxurion Externalisation Pharmaceutique
BRIEF published on 04/07/2026 at 18:05, 2 months 15 days ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
PRESS RELEASE published on 04/07/2026 at 18:00, 2 months 15 days ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
PRESS RELEASE published on 04/07/2026 at 18:00, 2 months 15 days ago Uitstel Gewone Algemene Vergadering Oxurion NV kondigt uitstel van de Jaarlijkse Vergadering van Aandeelhouders aan vanwege niet gefinaliseerde jaarrekening. Het bedrijf specialiseert zich in farmaceutische onderaannemers. Gevestigd in Leuven, België Oxurion NV Leuven Uitstel Jaarlijkse Vergadering Farmaceutisch
BRIEF published on 03/19/2026 at 18:35, 3 months 3 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
BRIEF published on 03/19/2026 at 18:35, 3 months 3 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 3 months 3 days ago Oxurion projette l'acquisition d'une CRO internationale Acquisition Stratégie De Croissance Développement Clinique Oxurion CRO Internationale
BRIEF published on 03/19/2026 at 18:35, 3 months 3 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 3 months 3 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 3 months 3 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
Published on 06/22/2026 at 21:05, 53 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 2 hours 13 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 6 hours ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 6 hours 28 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 6 hours 58 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 21:07, 50 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 1 hour 7 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 1 hour 25 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 2 hours 31 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 3 hours 3 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 3 hours 58 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
